Samuel N. Hazen - 31 Oct 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
CEO, Director
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
31 Oct 2025
Net transactions value
-$8,911,446
Form type
4
Filing time
04 Nov 2025, 18:16:35 UTC
Previous filing
15 May 2025
Next filing
18 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAZEN SAMUEL N CEO, Director ONE PARK PLAZA, NASHVILLE /s/ Kevin A. Ball, Attorney-in-Fact 04 Nov 2025 0001216838

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $4,039,119 +58,050 +337% $69.58 75,279 31 Oct 2025 Direct
transaction HCA Common Stock Tax liability $12,950,565 -28,173 -37% $459.68 47,106 31 Oct 2025 Direct
holding HCA Common Stock 14,979 31 Oct 2025 By HD Trust
holding HCA Common Stock 16,731 31 Oct 2025 By 2023 GST Trust
holding HCA Common Stock 93,088 31 Oct 2025 By 2023 Trust
holding HCA Common Stock 178,289 31 Oct 2025 By 2024 GRAT
holding HCA Common Stock 200,000 31 Oct 2025 By 2025 GRAT
holding HCA Common Stock 813,320 31 Oct 2025 By LP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -58,050 -100% $0.000000 0 31 Oct 2025 Common Stock 58,050 $69.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.